A handful of Houston startups will be bouncing back and forth to Austin for the second annual MassChallenge Texas accelerator. Photo via Getty Images

Meta has agreed to a $1.4 billion settlement with Texas in a privacy lawsuit over allegations that the tech giant used biometric data of users without their permission, officials said Tuesday.

Texas Attorney General Ken Paxton said the settlement is the largest secured by a single state. In 2021, a judge approved a $650 million settlement with the company, formerly known as Facebook, over similar allegations of users in Illinois.

“This historic settlement demonstrates our commitment to standing up to the world’s biggest technology companies and holding them accountable for breaking the law and violating Texans’ privacy rights,” Paxton, a Republican, said in a statement.

Meta said in a statement: “We are pleased to resolve this matter, and look forward to exploring future opportunities to deepen our business investments in Texas, including potentially developing data centers.”

Filed in 2022, the Texas lawsuit said that Meta was in violation of a state law that prohibits capturing or selling a resident's biometric information, such as their face or fingerprint, without their consent.

“This is by far the biggest state governmental privacy settlement in history,” Chicago-based class action attorney Jay Edelson said in an email. Edelson's firm filed the lawsuit that settled for $650 million with Meta. The only other larger claim is the Federal Trade Commission's $5 billion settlement with the company in 2019.

To date, Meta has now paid over $2 billion in settlements for biometric privacy claims, according to Edelson. “That is a huge signal to other companies that they should be extremely careful if they want to trade in individuals' biometric information,” he said.

The company announced in 2021 that it was shutting down its face-recognition system and delete the faceprints of more than 1 billion people amid growing concerns about the technology and its misuse by governments, police and others.

At the time, more than a third of Facebook’s daily active users had opted in to have their faces recognized by the social network’s system. Facebook introduced facial recognition more than a decade earlier but gradually made it easier to opt out of the feature as it faced scrutiny from courts and regulators.

Facebook in 2019 stopped automatically recognizing people in photos and suggesting people “tag” them, and instead of making that the default, asked users to choose if they wanted to use its facial recognition feature.

Texas filed a similar lawsuit against Google in 2022. Paxton’s lawsuit says the search giant collected millions of biometric identifiers, including voiceprints and records of face geometry, through its products and services like Google Photos, Google Assistant, and Nest Hub Max. That lawsuit is still pending.

The $1.4 billion is unlikely to make a dent in Meta’s business. The Menlo Park, California-based tech made a profit of $12.37 billion in the first three months of this year, Its revenue was $36.46 billion, an increase of 27% from a year earlier. Meta is scheduled to report its second-quarter earnings results on Wednesday.

Meta’s stock slipped $4.06 to $461.65 Tuesday, a decline of less than 1%.

Facebook is piloting a new tool at one of Houston's universities. Photo courtesy of Rice University

Facebook taps Houston college campus for new tool on its app

calling all underclassmen

Facebook launched as a social media platform solely for college students back in 2004. Since then, college students have gradually moved away from Mark Zuckerberg's baby in favor of platforms like Instagram, Snapchat, and TikTok.

Now, in a bid to once again attract college students, Facebook is returning to its roots with the introduction of a dedicated "college-only space" within the social media app. The social media giant is piloting Facebook Campus at 30 U.S. colleges and universities, including Houston's Rice University.

Harvard University, where Zuckerberg hatched Facebook, isn't among the pilot campuses. The only other Texas school in the pilot group is Stephen F. Austin University in Nacogdoches.

"While Facebook's early days saw it targeting Ivy League schools, the company says these first Facebook Campus schools were selected for diversity's sake. That is, diversity of the student population, diversity of geography, and diversity of school specialties (like liberal arts). They also represent a mix of public and private schools," the TechCrunch news website reports.

Facebook says a student's profile in the Campus section will differ from a student's profile on the main Facebook site. To create a Campus profile, a student must provide their college email address and graduation year. A student has the option to add information like major, courses, and hometown.

"Your name, profile photo, cover photo, and hometown from your Facebook profile will be added to your Campus profile, but you can edit or remove your hometown from your Campus profile if you'd like," Facebook tells prospective users.

Once a Campus profile is set up, a user can explore groups and events specific to their school, and connect with classmates who share similar interests. Only people on the Campus platform can view content posted there.

Features of Facebook Campus include:

  • Campus-specific news feed where students can read updates about classmates, groups, and events. They also can establish study groups, plan virtual concerts, or seek advice.
  • Directory of classmates at each campus. "Like in the early days when Facebook was a college-only network, students can find classmates by class, major, year, and more," Facebook says.
  • Real-time chat rooms for dorms and campus groups.

"This year, students across the country are facing new challenges as some campuses shift to partial or full-time remote learning, so it's more important than ever to find a way to stay connected to college life," Facebook says in a post about Facebook Campus. "College is a time for making new friends, finding people who share similar interests and discovering new opportunities to connect — from clubs to study groups, sports, and more."

With the Campus feature, Facebook hopes to lure younger users back to the platform in a setting where their parents and grandparents can't spy on them.

In the fall of 2019, U.S. teens named Snapchat as their favorite social media app (44 percent), followed by Instagram (35 percent) and TikTok (4 percent), according to Statista. Just 3 percent of teens cited Facebook as their favorite social media app.

By comparison, 42 percent of teens rated Facebook as their favorite social media network in 2012, followed by Twitter (27 percent) and Instagram (12 percent). Snapchat and TikTok had not yet been created.

"Most of us have [Facebook], we just never use it," one teen told CNBC last year. "It's not our thing."
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”